Stem cell inhibiting proteins
Patent Number: 5856301
Date of First Priority Issue: Wednesday December 23rd, 1992
Date Issued: Tuesday January 5th, 1999
Assignee: British Biotech Pharmaceuticals Limited (Oxford, GB)
Inventors: Craig, Stewart (Oxford, GB2); Hunter, Michael George (Buckinghamshire, GB2); Edwards, Richard Mark (Oxford, GB2); Czaplewski, Lloyd George (Oxford, GB2); Gilbert, Richard James (Oxford, GB2)
From Class: Expansion
Comments: No comments
This patent covers the inhibition of stem cell proliferation through administration of MIP-1 alpha or LD78. It is interesting to ask whether these compounds also inhibit proliferation of leukemic stem cells. If they do not, the use of these compounds may selectively protect healthy hematopoietic stem cells but allow killing of the leukemic hematopoietic stem cells by chemotherapy.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.